Keytruda (Pembrolizumab) - FDA Approved Immunotherapy Treatment for Cancer | Effective for Melanoma, Lung Cancer & More | Clinical Use in Oncology Hospitals

Pembrolizumab may be able to inhibit PD-1, thereby assisting the body's immune system in its efforts to eliminate cancer cells. It is a form of immunotherapy, and in order to help fight cancer, it collaborates with your immune system. Both a monoclonal antibody and an immune checkpoint inhibitor fall under the category of this substance. Additionally known as Keytruda.